Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 November 2020 | Story Ruan Bruwer | Photo Varsity Sports
Lefébre Rademan, the country’s top student netball player in 2019, has been snatched up by English netball club London Pulse to play in England in 2021.

 

Attempting to become an even better netballer, former Kovsies netball captain Lefébre Rademan decided to jet off to England to play in their league.

Rademan was contracted by London Pulse to compete in the European Superleague in 2021. She will be the fourth Kovsie after Maryka Holtzhausen (2015 and 2018-2019), Karla Pretorius (2016), and Khanyisa Chawane (2020) to play in the league.

Rademan said it was an easy decision, even though it will be far and a long time away from home. The league runs from February to July, with a pre-season in December. She will continue with her master’s degree at the University of the Free State next year.

“I am not going to play netball forever and such an opportunity doesn’t come often. Having competed against England, New Zealand, and Jamaica earlier in the year, I realised they play at a much higher level and if I want to improve and become the best, I would also need to move to a next level.”

“As a goal attack, having Protea teammate Sigi Burger (goal shooter) at the same club, will be an advantage for both of us and for the Proteas as a combination.”

Rademan has had a great past two years, making her Protea debut (12 tests in total) and receiving a number of accolades, such as the Varsity Netball Player of the Tournament in 2019.

In the Telkom Netball League in October, captaining the Free State Crinums, she was named Shooter of the Tournament. She was Player of the Match twice. Her goal average of 88,1% was the highest in the competition.

“Last year was such a good year for me personally, but that remains in the past. You can’t become complacent. I want to keep working hard and become a much better player,” Rademan said.

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept